Effect of octreotide on polycystic liver volume.
van Keimpema
Loes
L
Drenth
Joost P H
JP
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003560:Cysts / Q000188:drug therapy* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008107:Liver Diseases / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D009929:Organ Size / Q000187:drug effects; D018570:Risk Assessment; D012494:Sampling Studies; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D015282:Octreotide